Delivery Order SPE2DB22D1106-SPE2DB25FFAP9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Pregnyl 10,000 Unit Vials with a ceiling value of $3,022.50. This is a firm fixed price delivery order with an ultimate completion date of July 21, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,627.00 to AmerisourceBergen Drug Corp for Pregnyl 10,000 unit vials, with performance completed by July 23, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,813.50 to AmerisourceBergen Drug Corp for Pregnyl 10,000 unit vials, a human chorionic gonadotropin medication. The contract is a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and represents a non-competitive set-aside award to the prime contractor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical...
- This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency. The $1,174.52 firm fixed-price contract is for the delivery of PREGNYL 10,000 UNIT VIALS, a medical product, with a completion date of June 25, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical...
- This federal contract award is for the delivery of PREGNYL 10,000 UNIT VIALS to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract has a ceiling value of $2,418.00 and is a Firm Fixed Price Delivery Order, with a completion date of July 9, 2025. The contract is not set aside and was competed openly. Amerisourcebergen...
- This federal contract award, valued at $4,784.39, was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,415,725 units of Pregnyl 10,000 unit vials, a pharmaceutical product. The contract has an ultimate completion date of October 10, 2023 and is a firm fixed-price delivery order. The contract was awarded on October 6, 2023 and does not have a set-aside designation,...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 10,000 unit vials of the pharmaceutical product Pregnyl. The contract has a ceiling value of $1,255.56 and a performance period through March 27, 2024. This delivery order appears to be part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp,...
- This is a $1,155.65 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 10,000 unit vials of the medication Pregnyl, with a completion date of March 7, 2025. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pregnyl 10,000 unit vials, a pharmaceutical product, with a ceiling value of $1,029.90. The contract is a firm fixed-price, delivery order contract with a completion date of November 29, 2024. AmerisourceBergen is a for-profit organization and is registered in the System for...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 10,000-unit vials of the medication Pregnyl. The $2,418.00 contract has a performance period through June 23, 2025. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for various government...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFAP9Delivery Order
This delivery order, valued at $2,418.00, was awarded on July 30, 2025, to AmerisourceBergen Drug Corp for the supply of Pregnyl 10,000 unit vials. The contract, which is not set-aside and carries a firm fixed price structure, will be performed at the vendor's location in Conshohocken, Pennsylvania, with an ultimate completion date of July 31, 2025. The Defense Logistics Agency (DLA), under the Department of Defense, issued this award as part of its ongoing pharmaceutical procurement operations supporting military and federal healthcare systems. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical federal vendor specializing in a comprehensive range of medications, vaccines, medical devices, and healthcare commodities for military and federal medical supply chains. The company's established relationship with DLA and demonstrated capability to meet federal procurement requirements through competitive awards position it as a primary supplier for the department's pharmaceutical needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 7/30/25 |